Tasfigo tablets 35mg, manufactured by Eisai, contain Tazemetostat hydrobromide. This medication is used to treat certain sarcomas and follicular lymphomas, is standardized as 35mg per tablet, and has a YJ code of 4291087F1020.
Tasfigo tablets 35mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →